Yoshioka Masayuki, Oka Hisayoshi, Morita Masayo, Inoue Kiyoharu
Department of Neurology, Aoto Hospital, Jikei University School of Medicine.
Rinsho Shinkeigaku. 2003 Jul;43(7):379-84.
Autonomic dysfunction is often associated with the progression of Parkinson's disease (PD). The most frequent manifestations of autonomic dysfunction are cardiovascular symptoms, bladder and bowel dysfunction, and sudomotor dysfunction. However, sudomotor dysfunction in PD remains poorly understood. To evaluate sudomotor function in PD, we quantitatively measured sweating during untreated conditions in 20 patients with PD (age, 62 +/- 5 years) and in 10 age-matched control subjects (60 +/- 6 years). An evaporimeter can measure small amounts of water (g/m2h) evaporated from the body. This device was used to quantify sweating at different sites of the skin (forehead, arm, dorsal part of hand, chest wall, femur, and dorsal part of foot). Sweating demonstrated as amount of evaporated water (mean +/- SD g/m2h) was less in the patients with PD than in the control participants on the dorsal parts of the hand (13.7 +/- 5.2 vs. 23.9 +/- 5.5, p < 0.001) and foot (16.0 +/- 6.0 vs. 22.1 +/- 8.3, p < 0.05). On the dorsal part of the hand, sweating in the patients with PD at Yahr stages I and II was less than that in the control-Participants (15.2 +/- 6.3 vs. 23.9 +/- 5.5, p < 0.05). Sweating in the patients with PD at Yahr stages III and IV was less than that in the control participants on the dorsal parts of the hand (10.8 +/- vs. 2.7 vs. 23.9 +/- 5.5, p < 0.001), and foot (10.9 +/- 2.3 vs. 22.1 +/- 8.3, p < 0.005). Sweating on the dorsal part of the foot was less in the patients with PD at Yahr stages III and IV than that in those at Yahr stages I and II (10.9 +/- 2.3 vs. 18.4 +/- 6.1, p < 0.05). Sweating on the forehead in the patients with PD at Yahr stages I and II stage was slightly but not significantly less than that in the control participants (21.8 +/- 3.8 vs. 32.7 +/- 11.9, p < 0.2). Sweating on the forehead in the patients with PD at Yahr stages III and IV was sightly but not significantly greater than that in those at Yahr stages I and II (25.4 +/- 5.6 vs. 21.8 +/- 3.8, p < 0.2). Increased sweating on the forehead skin might compensate for decreased sweating on the extremital skin. Our results suggest that sudomotor dysfunction in PD primarily affects the distal parts of the upper and lower extremities. Sudomotor dysfunction affecting distal parts of the extremities worsens with increased severity of PD.
自主神经功能障碍常与帕金森病(PD)的进展相关。自主神经功能障碍最常见的表现是心血管症状、膀胱和肠道功能障碍以及汗腺功能障碍。然而,PD中的汗腺功能障碍仍了解甚少。为评估PD中的汗腺功能,我们对20例PD患者(年龄62±5岁)和10例年龄匹配的对照者(60±6岁)在未治疗状态下的出汗情况进行了定量测量。蒸发仪可测量从身体蒸发的少量水分(克/平方米·小时)。该设备用于量化皮肤不同部位(额头、手臂、手背、胸壁、股骨和脚背)的出汗情况。以蒸发水分量(平均值±标准差,克/平方米·小时)表示的出汗量,PD患者在手背(13.7±5.2 vs. 23.9±5.5,p<0.001)和脚背(16.0±6.0 vs. 22.1±8.3,p<0.05)部位比对照者少。在手背部位,处于雅尔分期I和II期的PD患者出汗量少于对照者(15.2±6.3 vs. 23.9±5.5,p<0.05)。处于雅尔分期III和IV期的PD患者在手背(10.8±2.7 vs. 23.9±5.5,p<0.001)和脚背(10.9±2.3 vs. 22.1±8.3,p<0.005)部位出汗量少于对照者。处于雅尔分期III和IV期的PD患者脚背出汗量少于处于雅尔分期I和II期的患者(10.9±2.3 vs. 18.4±6.1,p<0.05)。处于雅尔分期I和II期的PD患者额头出汗量略少于对照者,但差异无统计学意义(21.8±3.8 vs. 32.7±11.9,p<0.2)。处于雅尔分期III和IV期的PD患者额头出汗量略多于处于雅尔分期I和II期的患者(25.4±5.6 vs. 21.8±3.8,p<0.2)。额头皮肤出汗增加可能是为了补偿四肢皮肤出汗减少。我们的结果表明,PD中的汗腺功能障碍主要影响上下肢远端。随着PD病情严重程度增加,影响四肢远端的汗腺功能障碍会加重。